A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage

NCT01661140 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate (stable dose)
DRUG: Tocilizumab
DRUG: Methotrexate (tapering dose)

Sponsor

Hoffmann-La Roche